Developer site: The content shown here is test data.

Health Dictionary AI Health Chat Find an Online Doctor
A serene Zen garden with raked sand and smooth stones, symbolising clarity and calm

Health Dictionary

Back to skin conditions

Ventricular fibrillation risk factors

Introduction

Overview

Overview

Common risk factors associated with the development of ventricular fibrillation include history of myocardial infarction, congenital heart disease, electrolyte abnormalities and etc.

Risk Factors

Risk Factors

Risk factors for the development of ventricular fibrillation in general population may include:[1][2][3][4][5][6][7]

Risk factors for the development of ventricular fibrillation especially in the setting of acute myocardial infarction include:[8][9][10]

In one nationwide study, ventricular fibrillation in the setting of acute myocardial infarction was associated with following risk factors:[11]

References

References

  1. ↑ Khairy P (November 2016). “Ventricular arrhythmias and sudden cardiac death in adults with congenital heart disease”. Heart. 102 (21): 1703–1709. doi:10.1136/heartjnl-2015-309069. PMIDΒ 27250216.
  2. ↑ Maury P, Sacher F, Rollin A, Mondoly P, Duparc A, Zeppenfeld K, Hascoet S (May 2017). “Ventricular arrhythmias and sudden death in tetralogy of Fallot”. Arch Cardiovasc Dis. 110 (5): 354–362. doi:10.1016/j.acvd.2016.12.006. PMIDΒ 28222965.
  3. ↑ Saumarez RC, Camm AJ, Panagos A, Gill JS, Stewart JT, de Belder MA, Simpson IA, McKenna WJ (August 1992). “Ventricular fibrillation in hypertrophic cardiomyopathy is associated with increased fractionation of paced right ventricular electrograms”. Circulation. 86 (2): 467–74. doi:10.1161/01.cir.86.2.467. PMIDΒ 1638716.
  4. ↑ Bektas, Firat; Soyuncu, Secgin (2012). “Hypokalemia-induced Ventricular Fibrillation”. The Journal of Emergency Medicine. 42 (2): 184–185. doi:10.1016/j.jemermed.2010.05.079. ISSNΒ 0736-4679.
  5. ↑ Klasner, Ann E; Scalzo, Anthony J; Blume, Carolyn; Johnson, Paul; Thompson, Michael W (1996). “Marked Hypocalcemia and Ventricular Fibrillation in Two Pediatric Patients Exposed to a Fluoride-Containing Wheel Cleaner”. Annals of Emergency Medicine. 28 (6): 713–718. doi:10.1016/S0196-0644(96)70097-5. ISSNΒ 0196-0644.
  6. ↑ Billman GE, Hoskins RS (November 1988). “Cocaine-induced ventricular fibrillation: protection afforded by the calcium antagonist verapamil”. FASEB J. 2 (14): 2990–5. doi:10.1096/fasebj.2.14.3181653. PMIDΒ 3181653.
  7. ↑ Heist, E. Kevin; Ruskin, Jeremy N. (2010). “Drug-Induced Arrhythmia”. Circulation. 122 (14): 1426–1435. doi:10.1161/CIRCULATIONAHA.109.894725. ISSNΒ 0009-7322.
  8. ↑ Gheeraert PJ, Henriques JP, De Buyzere ML, Voet J, Calle P, Taeymans Y, Zijlstra F (January 2000). “Out-of-hospital ventricular fibrillation in patients with acute myocardial infarction: coronary angiographic determinants”. J. Am. Coll. Cardiol. 35 (1): 144–50. doi:10.1016/s0735-1097(99)00490-8. PMIDΒ 10636272.
  9. ↑ Dekker LR, Bezzina CR, Henriques JP, Tanck MW, Koch KT, Alings MW, Arnold AE, de Boer MJ, Gorgels AP, Michels HR, Verkerk A, Verheugt FW, Zijlstra F, Wilde AA (September 2006). “Familial sudden death is an important risk factor for primary ventricular fibrillation: a case-control study in acute myocardial infarction patients”. Circulation. 114 (11): 1140–5. doi:10.1161/CIRCULATIONAHA.105.606145. PMIDΒ 16940195.
  10. ↑ Gheeraert PJ, Henriques JP, De Buyzere ML, De Pauw M, Taeymans Y, Zijlstra F (November 2001). “Preinfarction angina protects against out-of-hospital ventricular fibrillation in patients with acute occlusion of the left coronary artery”. J. Am. Coll. Cardiol. 38 (5): 1369–74. doi:10.1016/s0735-1097(01)01561-3. PMIDΒ 11691510.
  11. ↑ Jabbari R, EngstrΓΈm T, Glinge C, Risgaard B, Jabbari J, Winkel BG, Terkelsen CJ, Tilsted HH, Jensen LO, Hougaard M, Chiuve SE, Pedersen F, Svendsen JH, HaunsΓΈ S, Albert CM, Tfelt-Hansen J (January 2015). “Incidence and risk factors of ventricular fibrillation before primary angioplasty in patients with first ST-elevation myocardial infarction: a nationwide study in Denmark”. J Am Heart Assoc. 4 (1): e001399. doi:10.1161/JAHA.114.001399. PMCΒ 4330064. PMIDΒ 25559012.

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Sahar Memar Montazerin, M.D.[2]